🎄Wishing you a happy holiday season filled with prosperity, joy, and renewal. As we look toward the future, we extend our heartfelt gratitude to our community. 🌟 2025 draws near, let’s continue to collaborate and amplify our impact in the year ahead. Together, we can reach new heights and achieve even more! ✨ #MerryChristmas #HappyNewYear #SeasonsGreetings
Sebia
Fabrication d’équipements médicaux
Lisses, Île-de-France 15 376 abonnés
A Global specialized In Vitro Diagnostic player
À propos
Founded in 1967, Sebia is a Global specialty In Vitro Diagnostic leader for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy, Autoimmunity and other rare pathologies. Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language. We call it our new language of life. Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in technologies, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.
- Site web
-
https://www.sebia.com
Lien externe pour Sebia
- Secteur
- Fabrication d’équipements médicaux
- Taille de l’entreprise
- 1 001-5 000 employés
- Siège social
- Lisses, Île-de-France
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 1967
- Domaines
- Medical & Laboratory diagnostics, Diagnostics instruments, in vitro diagnostics, capillary electrophoresis, gel electrophoresis, ELISA, IFA, CLIA, Mass Spectometry, Multiple Myeloma, Diabetes, Hemoglobin Disorders, Alcoholism, von Willebrand Disease, Rheumatoid Arthritis, Connective Tissue Disease, Vasculitis, Antiphospholipid Syndrome, Gastroenterological Diseases, Thyroid Disease et Bacteriology/Virology
Lieux
-
Principal
27, Rue Léonard de Vinci
91090 Lisses, Île-de-France, FR
Employés chez Sebia
Nouvelles
-
[𝟲𝟲𝘁𝗵 #𝗔𝗦𝗛 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗘𝘅𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻] 🇺🇸 What an amazing ASH24! 🌟 Such great opportunity to connect with Patients associations, Clinicians and Pharma colleagues and discuss how innovative 𝐌𝐑𝐃 𝐁𝐥𝐨𝐨𝐝 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 🩸 can replace invasive bone marrow procedures. Thank you to everyone who has visited our ASH24 booth, stay connected with our #Sebia M-inSight team! 👩⚕️👨⚕️ #ASH24 #MultipleMyeloma #Minsight #BloodbasedMRD #Hematology #Oncology
-
[𝟲𝟲𝘁𝗵 𝗔𝗦𝗛 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗘𝘅𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻] 🇺🇸 We are excited to be in San Diego at #ASH! Meet our team on the #Sebia Booth #3209 to learn more about our specialty #diagnostic solutions offering and M-Insight®, the ultrasensitive blood test for # MRD monitoring in # multiple myeloma patient! 📍 Location: San Diego, CA 🔍 Booth Number: 3209 #ASH24 #multiplemyeloma #minsight #MRD #bloodbasedMRD
-
[𝟲𝟲𝘁𝗵 𝗔𝗦𝗛 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗘𝘅𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻] 🇺🇸 #Sebia is recognized as a worldwide leader in #diagnosis and #monitoring of #Myeloma Patients thanks to our historical expertise and our outstanding comprehensive offer. (#SPE, IT/IF, #FLC, #HYDRASHIFT) Will you be at #ASH24? Visit the Sebia Booth to learn more about Sebia Solutions. 𝐒𝐜𝐡𝐞𝐝𝐮𝐥𝐞 𝐲𝐨𝐮𝐫 𝐚𝐩𝐩𝐨𝐢𝐧𝐭𝐦𝐞𝐧𝐭 𝐭𝐨𝐝𝐚𝐲 👉 https://lnkd.in/eSP6eCNW 🌟 Event Details 🌟 🗓️ Dates: December 7th - 10th, 2024 📍 Location: San Diego, CA #ASH24 #multiplemyeloma #minsight #bloodbasedMRD #Hematology #Oncology
-
[𝟲𝟲𝘁𝗵 𝗔𝗦𝗛 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗘𝘅𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻] 🇺🇸 Will you be at the #ASH Annual Meeting in San Diego? Visit our team of experts on-site and mark your calendar to view our Poster highlighting blood-based mass spectrometry for tracking #MRD in Multiple Myeloma. 🌟 Event Details 🌟 🗓️ Dates: December 7th - 10th, 2024 📍 Location: San Diego, CA Schedule time with our team of experts to learn more: https://lnkd.in/eM-wvW3X #Sebia #ASH24 #Multiplemyeloma #Minsight #MRD #bloodbasedMRD #Hematology #Oncology
-
[𝟲𝟲𝘁𝗵 𝗔𝗦𝗛 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗘𝘅𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻] 🇺🇸 Visit #Sebia at #ASH in San Diego, 𝗕𝗼𝗼𝘁𝗵 #𝟯𝟮𝟬𝟵 to hear about M-inSight®, our serum-based test for monitoring #MRD in Multiple #Myeloma. 🌟 Event Details 🌟 🗓️ Dates: December 7th - 10th, 2024 📍 Location: San Diego, CA 🌐 Discover M-inSight®: https://lnkd.in/e4Q5C-9s #ASH24 #Multiplemyeloma #Minsight #bloodbasedMRD
-
[𝟲𝟲𝘁𝗵 𝗔𝗦𝗛 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗘𝘅𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻] 🇺🇸 We are excited to attend the #ASH Annual Meeting starting December 7th in San Diego! Mark your calendar to visit the #Sebia Team at 𝗕𝗼𝗼𝘁𝗵 #𝟯𝟮𝟬𝟵 to learn about world-leading solutions for multiple #Myeloma patient testing! 🔬 🗓️ Dates: December 7th - 10th, 2024 📍 Location: San Diego, CA 🔍 Booth Number: 3209 🌐 For more information: https://lnkd.in/ei__zFPu 💬 Let’s connect at #ASH24! 🤝 #MultipleMyeloma #ASH24 #Sebiausa #Minsight #Hematology #Oncology
-
🔵 World Diabetes Day 🌍 reminds us that people with diabetes need to engage in daily self-management and make major lifestyle changes, and that the resulting emotional burden can cause significant distress. 📊 𝐇𝐛𝐀𝟏𝐜 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐢𝐬 𝐚𝐧 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐭𝐨𝐨𝐥 𝐢𝐧 𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭. And for patients knowing their HbA1c levels gives a tangible measure of their progress. Patients feel better able to manage their disease and make positive lifestyle changes, resulting in improved well-being and better health. Let's continue supporting and empowering everyone on this journey!✨ #WorldDiabetesDay #DiabetesManagement #HbA1c #Sebia #EmpowerPatients
-
🟣 World Amyloidosis Day 🌍 October 26th 𝐀𝐋 𝐀𝐦𝐲𝐥𝐨𝐢𝐝𝐨𝐬𝐢𝐬 𝐢𝐬 𝐚 𝐫𝐚𝐫𝐞 𝐛𝐮𝐭 𝐬𝐞𝐫𝐢𝐨𝐮𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐚𝐟𝐟𝐞𝐜𝐭𝐢𝐧𝐠 𝐦𝐚𝐧𝐲 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐰𝐨𝐫𝐥𝐝𝐰𝐢𝐝𝐞. On this day, we highlight the importance of early detection and proper treatment. 🧬 𝐅𝐫𝐞𝐞 𝐋𝐢𝐠𝐡𝐭 𝐂𝐡𝐚𝐢𝐧𝐬 (FLC) play a crucial role in the diagnosis and monitoring of this condition. Using FLC tests allows for early detection of abnormalities, enabling quick and appropriate intervention. Sebia offers global solutions to help diagnosing and monitoring AL Amyloidosis, from FLC assays to 🧪 Serum / Urine Protein Electrophoresis and Immunotyping / Immunofixation. 🎬Watch our 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 𝐫𝐞𝐩𝐥𝐚𝐲 𝐨𝐧 𝐀𝐋 𝐀𝐦𝐲𝐥𝐨𝐢𝐝𝐨𝐬𝐢𝐬 to learn more: https://lnkd.in/eGV6cug3 Together, let's raise awareness and support research to improve the lives of those affected by AL Amyloidosis. 💪 #WorldALAmyloidosisDay #ALAmyloidosis #Health #FLC #EarlyDiagnosis #Bethelink
-
📅 Mark Your Calendar for an Insightful Educational Webinar! Join us on November 13, 2024, at 1:00 PM EDT for an in-depth discussion on the use of Capillary Electrophoresis for Hemoglobinopathy and Thalassemia Evaluation with a focus on real-world, case-based approaches. Our expert panel includes: 🩺 Dr. Mark Girton & 🩺 Dr. Matthew C. Wagner Together, they will review complex patient cases and explore the latest advancements in capillary electrophoresis for hemoglobinopathies, including thalassemia diagnosis and management. Whether you’re a seasoned lab professional or looking to deepen your knowledge in this area, this webinar is a must-attend! ✅ Secure your spot today and gain valuable insights into how capillary electrophoresis can improve patient outcomes. 🔗 Register here: https://lnkd.in/dy5GMKiC #Hemoglobinopathy #Thalassemia #CapillaryElectrophoresis #LabScience #LabTesting #Webinar #Sebia